Skip to the page

Data / Form D filings / Qidni Labs Inc.

Qidni Labs Inc.: Form D filing

Qidni Labs Inc., a biotechnology company in Kitchener, Ontario, Canada, filed a Form D with the SEC in 2023. The latest, on June 5, 2023, reports $730,000 sold of a $780,000 offering to 16 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
151 CHARLES STREET WEST, SUITE 199, Kitchener, Ontario, Canada, N2G 1
Phone
(226) 606-0956
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1980232

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 5, 2023New notice$780,000$730,000$50,00016May 18, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Martha FarmerDirector
William NyhanDirector
Morteza AhmadiExecutive Officer, Director

Every Form D from the week of Jun 5, 2023 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Qidni Labs Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.